Elpida Therapeutics, Catalent Partner for Late-Phase AAV Manufacturing

FierceBiotechIcon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities

Endpoints NewsValneva to cut up to 15% of jobs as reduced travel hits vaccine demand

WatersWaters Corporation stock (US9418481035): Analytical instruments leader for US life sciences - AD HOC NEWS

BioPharma DiveFDA’s leadership void leaves biotech with renewed ‘uncertainty’

Endpoints NewsAbeona pivots to T cells; AstraZeneca's rare disease drug passes Phase 3

BioPharma DiveLilly data point to ‘maintenance’ strategies for GLP-1 weight loss

FierceBiotechHumacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant

FierceBiotechWith $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’

BioWorldNvision secures $55 million, with backing from Abbott

BioWorldAppointments and advancements for May 13, 2026

BioWorldFinancings for May 13, 2026

BioWorldIn the clinic for May 13, 2026